Intraductal Papillary Mucinous Neoplasms of the Pancreas: Cytologic-histologic Correlation Study and Evaluation of the Cytologic Accuracy in Identifying High-grade Dysplasia/invasive Adenocarcinoma

Overview

Journal Cytojournal

Date 2024 Feb 12

PMID 38343764

Authors

Serenella Serinelli

Kamal K Khurana

Affiliations

Soon will be listed here.

Abstract

Objective: Intraductal papillary mucinous neoplasms (IPMNs) may be associated with invasive adenocarcinoma, low-grade dysplasia (LGD), or high-grade dysplasia (HGD). We aimed to review the cytologic-histologic correlation of cases with a histologic diagnosis of IPMN.

Material And Methods: A database search (January 2010-January 2021) was performed for resected IPMNs with preceding endoscopic ultrasound-guided fine-needle aspiration (FNA). Cytology slides were reviewed for the presence of benign, atypical, or malignant cells, and necrosis. Histologically, IPMNs were classified as benign (LGD) or malignant (HGD or adenocarcinoma).

Results: There were 41 patients with IPMN; 24 malignant and 17 benign. Sixteen of the 24 malignant IPMNs were accurately classified as malignant on cytology. There were eight false negatives and one false positive. Cytology yielded a sensitivity of 67% and a specificity of 94%. Among the 16 true positives with FNA diagnosis of adenocarcinoma, seven were IPMNs with HGD, and nine had invasive adenocarcinomas on histology. Cellular morphology and absence or presence of necrosis did not help distinguish HGD from adenocarcinoma on cytology ( > 0.5). Sampling errors and interpretative errors resulted in false-negative cases. Cytology yielded diagnoses related to IPMN in 73% of cases (30/41) and lack of identification of mucinous cells/mucinous background resulted in interpretative errors (9).

Conclusion: This study shows that there is a good correlation between cytopathology and surgical pathology diagnoses of IPMNs and that cytology is mostly able to recognize IPMN with HGD/adenocarcinoma. However, heterogeneity in areas of IPMN with HGD/adenocarcinoma may result in sampling errors yielding false-negative cases. Mucinous cells/background should raise the suspicion of IPMN on cytology, even when no neoplastic epithelium is present for the evaluation of dysplasia.

Citing Articles

Advances in Endoscopic Ultrasonography-Based Diagnosis of Pancreatic Lesions: Narrative Review.

Yamashita Y, Yamazaki H, Nakahata A, Emori T, Kawaji Y, Tamura T Cancers (Basel). 2025; 17(2).

PMID: 39857954 PMC: 11764399. DOI: 10.3390/cancers17020172.

References

Adsay V, Mino-Kenudson M, Furukawa T, Basturk O, Zamboni G, Marchegiani G . Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. Ann Surg. 2015; 263(1):162-77. PMC: 4568174. DOI: 10.1097/SLA.0000000000001173. View

Lim J, Lee G, Oh Y . Radiologic spectrum of intraductal papillary mucinous tumor of the pancreas. Radiographics. 2001; 21(2):323-37; discussion 337-40. DOI: 10.1148/radiographics.21.2.g01mr01323. View

Smith A, Abdul-Karim F, Goyal A . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathol. 2015; 124(4):285-93. DOI: 10.1002/cncy.21657. View

Arnelo U, Siiki A, Swahn F, Segersvard R, Enochsson L, Del Chiaro M . Single-operator pancreatoscopy is helpful in the evaluation of suspected intraductal papillary mucinous neoplasms (IPMN). Pancreatology. 2014; 14(6):510-4. DOI: 10.1016/j.pan.2014.08.007. View

Inoue H, Tsuchida A, Kawasaki Y, Fujimoto Y, Yamasaki S, Kajiyama G . Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity. Cancer. 2001; 91(1):35-41. DOI: 10.1002/1097-0142(20010101)91:1<35::aid-cncr5>3.0.co;2-a. View

Adsay N, Pierson C, Sarkar F, Abrams J, Weaver D, Conlon K . Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol. 2001; 25(1):26-42. DOI: 10.1097/00000478-200101000-00003. View

Kloppel G, Basturk O, Schlitter A, Konukiewitz B, Esposito I . Intraductal neoplasms of the pancreas. Semin Diagn Pathol. 2014; 31(6):452-466. DOI: 10.1053/j.semdp.2014.08.005. View

Stelow E, Stanley M, Bardales R, Mallery S, Lai R, Linzie B . Intraductal papillary-mucinous neoplasm of the pancreas. The findings and limitations of cytologic samples obtained by endoscopic ultrasound-guided fine-needle aspiration. Am J Clin Pathol. 2003; 120(3):398-404. DOI: 10.1309/CEPK-542W-3885-2LP8. View

Tanaka M . Intraductal papillary mucinous neoplasm of the pancreas: diagnosis and treatment. Pancreas. 2004; 28(3):282-8. DOI: 10.1097/00006676-200404000-00013. View

10.

Kim H, Jang J . Management Algorithms for Pancreatic Cystic Neoplasms. Arch Pathol Lab Med. 2021; 146(3):322-329. DOI: 10.5858/arpa.2020-0395-RA. View

11.

Lee S, Park S, Hwang D, Lee J, Song K, Lee W . Surgical Decisions Based on a Balance between Malignancy Probability and Surgical Risk in Patients with Branch and Mixed-Type Intraductal Papillary Mucinous Neoplasm. J Clin Med. 2020; 9(9). PMC: 7565903. DOI: 10.3390/jcm9092758. View

12.

Adsay N, Conlon K, Zee S, Brennan M, Klimstra D . Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer. 2002; 94(1):62-77. DOI: 10.1002/cncr.10203. View

13.

Layfield L, Cramer H . Fine-needle aspiration cytology of intraductal papillary-mucinous tumors: a retrospective analysis. Diagn Cytopathol. 2004; 32(1):16-20. DOI: 10.1002/dc.20149. View

14.

Ozcan K, Klimstra D . A Review of Mucinous Cystic and Intraductal Neoplasms of the Pancreatobiliary Tract. Arch Pathol Lab Med. 2022; 146(3):298-311. DOI: 10.5858/arpa.2021-0399-RA. View

15.

Duconseil P, Perinel J, Autret A, Adham M, Sauvanet A, Chiche L . Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two different diseases receive the same treatment? A matched comparison study of the French Surgical Association (AFC). Eur J Surg Oncol. 2017; 43(9):1704-1710. DOI: 10.1016/j.ejso.2017.06.011. View

16.

Delatour N, Policarpio-Nicolas M, Yazdi H, Islam S . Fine needle aspiration biopsy for preoperative workup of pancreatic cystic neoplasms: report of 4 cases. Acta Cytol. 2007; 51(6):925-33. DOI: 10.1159/000325872. View

17.

Abdelkader A, Hunt B, Hartley C, Panarelli N, Giorgadze T . Cystic Lesions of the Pancreas: Differential Diagnosis and Cytologic-Histologic Correlation. Arch Pathol Lab Med. 2019; 144(1):47-61. DOI: 10.5858/arpa.2019-0308-RA. View

18.

Springfeld C, Ferrone C, Katz M, Philip P, Hong T, Hackert T . Neoadjuvant therapy for pancreatic cancer. Nat Rev Clin Oncol. 2023; 20(5):318-337. DOI: 10.1038/s41571-023-00746-1. View

19.

Maire F, Hammel P, Terris B, Olschwang S, OToole D, Sauvanet A . Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. Gut. 2002; 51(3):446-9. PMC: 1773367. DOI: 10.1136/gut.51.3.446. View

20.

Hirabayashi K, Saika T, Nakamura N . Background features in the cytology of pancreatic neoplasms. DEN Open. 2022; 2(1):e105. PMC: 9302047. DOI: 10.1002/deo2.105. View